Biologics and Biosimilars in the U.S. and Europe

Events / May 24-26, 2016
1:00-4:30 p.m.

Tuesday, May 24, 2016

Hyatt Regency Cambridge
Overlooking Boston,
575 Memorial Drive
Cambridge, MA 02139

Register Now >>

Wednesday, May 25, 2016

Princeton Marriott at Forrestal
100 College Road East
Princeton, NJ 08540

Register Now >>

Thursday, May 26, 2016

Hilton Garden Inn
14975 Shady Grove Road
Rockville, MD 20850

Register Now >>

As the pace of biosimilar development picks up, many pharmaceutical companies are looking for guidance in understanding the patent and regulatory landscapes in the United States and in Europe. This seminar will provide practical advice on the most recent legal developments, preparing for biosimilar approval and patent and litigation strategies.

Our speakers from BakerHostetler and Carpmaels & Ransford LLP have in-depth knowledge of the current state of play in the biologic and biosimilars field and will share their insights on best practices to find success in this rapidly developing area of the pharmaceutical industry.

BakerHostetler presenters:
  • S. Maurice Valla, Partner, Philadelphia
  • Felicity E. Groth, Partner, Philadelphia
  • Benjamin C. Hsing, Partner, New York
  • Gary H. Levin, Partner, Philadelphia
  • Lance L. Shea, Partner, Washington, D.C.
Carpmaels & Ransford presenters:
  • Hugh Goodfellow, Partner, London
  • Camilla Balleny, Partner, London
  • Daniel Wise, Partner, London
  • David Wilson, Partner, London
  • Stephen Duffield, Senior Associate, London

Please click here for a brief on Causal Leverage Analysis, and here for a brief on IP Strategies in the Emerging Biosimilar Market

3.0 hours of CLE credit (available in CA, DE, NJ, NY, PA and RI; pending in VA)

For questions, please contact Dan Greenspan at 215.564.6525.

Related Services